BACKGROUND: The impact of loop electrosurgical excision procedure (LEEP) treatment for cervical precancerous lesions on subsequent acquisition of new human papillomavirus (HPV) infections is not well described. METHODS: The acquisition of new HPV infections was compared in HPV-positive women who underwent colposcopy and were treated by LEEP (n = 195) and those who were untreated (n = 1625) at entry into a 2-year study. Cumulative incidence rate ratios (IRRs) for treated versus untreated women at 6- and 24-months of follow-up, with 95% confidence intervals (CIs), were calculated for infection by individual HPV genotypes, any HPV genotypes, any carcinogenic HPV genotypes, any noncarcinogenic HPV genotypes, and phylogenetic groups of HPV genotypes. RESULTS: Treated women were 29% less likely than untreated women to have carcinogenic HPV genotypes detected at 6-month follow-up visits (IRR, 0.71; 95% CI, 0.50-1.00) and were 18% less likely to have these genotypes detected at 24-month follow-up visits (IRR, 0.82; 95% CI, 0.68-1.01). Treated women were 56% less likely to have HPV genotypes of the alpha9 phylogenetic species (which includes HPV-16) detected at 6-month follow-up visits (IRR, 0.44; 95% CI, 0.23-0.85) and were 40% less likely to have these genotype detected at 24-month follow-up visits (IRR, 0.60; 95% CI, 0.42-0.85). CONCLUSION: LEEP may reduce the acquisition of certain carcinogenic HPV genotypes related to HPV-16.
BACKGROUND: The impact of loop electrosurgical excision procedure (LEEP) treatment for cervical precancerous lesions on subsequent acquisition of new humanpapillomavirus (HPV) infections is not well described. METHODS: The acquisition of new HPV infections was compared in HPV-positive women who underwent colposcopy and were treated by LEEP (n = 195) and those who were untreated (n = 1625) at entry into a 2-year study. Cumulative incidence rate ratios (IRRs) for treated versus untreated women at 6- and 24-months of follow-up, with 95% confidence intervals (CIs), were calculated for infection by individual HPV genotypes, any HPV genotypes, any carcinogenic HPV genotypes, any noncarcinogenic HPV genotypes, and phylogenetic groups of HPV genotypes. RESULTS: Treated women were 29% less likely than untreated women to have carcinogenic HPV genotypes detected at 6-month follow-up visits (IRR, 0.71; 95% CI, 0.50-1.00) and were 18% less likely to have these genotypes detected at 24-month follow-up visits (IRR, 0.82; 95% CI, 0.68-1.01). Treated women were 56% less likely to have HPV genotypes of the alpha9 phylogenetic species (which includes HPV-16) detected at 6-month follow-up visits (IRR, 0.44; 95% CI, 0.23-0.85) and were 40% less likely to have these genotype detected at 24-month follow-up visits (IRR, 0.60; 95% CI, 0.42-0.85). CONCLUSION: LEEP may reduce the acquisition of certain carcinogenic HPV genotypes related to HPV-16.
Authors: P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: K L Liaw; A Hildesheim; R D Burk; P Gravitt; S Wacholder; M M Manos; D R Scott; M E Sherman; R J Kurman; A G Glass; S M Anderson; M Schiffman Journal: J Infect Dis Date: 2000-11-16 Impact factor: 5.226
Authors: Philip E Castle; Sholom Wacholder; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G Glass; Brenda B Rush; John E Schussler; Mark Schiffman Journal: J Natl Cancer Inst Date: 2002-09-18 Impact factor: 13.506
Authors: Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer Journal: N Engl J Med Date: 2003-02-06 Impact factor: 91.245
Authors: Rachel L Winer; Shu-Kuang Lee; James P Hughes; Diane E Adam; Nancy B Kiviat; Laura A Koutsky Journal: Am J Epidemiol Date: 2003-02-01 Impact factor: 4.897
Authors: A Aerssens; P Claeys; E Beerens; A Garcia; S Weyers; L Van Renterghem; M Praet; M Temmerman; R Velasquez; C A Cuvelier Journal: Cytopathology Date: 2008-05-28 Impact factor: 2.073
Authors: Anne F Rositch; Heidi M Soeters; Tabatha N Offutt-Powell; Bradford S Wheeler; Sylvia M Taylor; Jennifer S Smith Journal: Gynecol Oncol Date: 2014-01-07 Impact factor: 5.482
Authors: Belinda Nedjai; Caroline Reuter; Amar Ahmad; Rawinder Banwait; Rhian Warman; James Carton; Sabrina Boer; Jack Cuzick; Attila T Lorincz Journal: Int J Cancer Date: 2018-07-03 Impact factor: 7.396